# SS-31 elamipretide: single dose and aging muscle energy

Source: https://pepvault.app/research/ss-31-roshanravan-2021

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [SS-31](https://pepvault.app/research#ss-31)

Randomized trial · people

# SS-31 raised muscle ATP capacity after one dose in older adults

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

One elamipretide infusion briefly raised mitochondrial energy capacity in older human muscle, but in this trial that short-lived gain did not make the muscle more resistant to fatigue.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 39
- **Published:** 2021
- **Journal:** PLoS One

## What they tested

The team tested whether a single dose of elamipretide could improve how well mitochondria, the energy-making parts of cells, work in the muscle of older adults.

## How the study was done

A randomized, double-blind, placebo-controlled trial in 39 healthy adults aged 60 to 85 (46% women), chosen because their mitochondria worked poorly. Each got one 2-hour infusion of elamipretide or placebo (a dummy treatment), and the team measured a hand muscle, the first dorsal interosseous, right after the infusion and again on day 7.

<!--promo-->

PepVault for iPhone

## Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Right after the infusion, the elamipretide group showed higher ATPmax than the placebo group. ATPmax is the peak rate at which muscle mitochondria make ATP, the cell's energy molecule, during exercise. The difference had P = 0.055 for the absolute change and P = 0.045 for the percent change, and by day 7 the groups no longer differed. Mitochondrial coupling at rest (P/O, how much ATP is made per unit of oxygen used) did not change significantly, and there was no significant effect on fatigue resistance during repeated contractions.

## What it doesn’t show

This was one dose in a small group, measured in a single hand muscle of healthy older adults. The boost faded within a week, did not improve fatigue resistance, and the absolute change in ATPmax fell just short of the usual significance cutoff.

## The paper

Roshanravan et al. In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial. PLoS One. 2021.

- [PubMed (PMID 34264994)](https://pubmed.ncbi.nlm.nih.gov/34264994/)
- [The paper (DOI 10.1371/journal.pone.0253849)](https://doi.org/10.1371/journal.pone.0253849)

## The compound

- [SS-31: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)

## With this study

### SS-31

- [SS-31: the full reference](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-50mg)

### Studies

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024)
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023)
- [SS-31: no 12-week benefit, walk gains by 36 weeks open-label](https://pepvault.app/research/ss-31-reid-thompson-2021)
- [All 12 studies](https://pepvault.app/research#ss-31)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Unit (on a syringe)](https://pepvault.app/glossary/syringe-units)
- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on SS-31

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024) Randomized trial · people · 2024
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023) Randomized trial · people · 2023
- [SS-31: no 12-week benefit, walk gains by 36 weeks open-label](https://pepvault.app/research/ss-31-reid-thompson-2021) Randomized trial · people · 2021
- [SS-31: walk distance rose with dose in 5-day MMPOWER trial](https://pepvault.app/research/ss-31-mmpower-2018) Randomized trial · people · 2018
- [SS-31: less kidney hypoxia after renal artery stenting in pilot](https://pepvault.app/research/ss-31-saad-2017) Randomized trial · people · 2017
- [SS-31 did not significantly cut infarct size in EMBRACE STEMI](https://pepvault.app/research/ss-31-embrace-stemi-2016) Randomized trial · people · 2016
- [Every study on SS-31](https://pepvault.app/research#ss-31)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### SS-31

- [SS-31: the full reference](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ss-31-50mg)

### Studies

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024)
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023)
- [SS-31: no 12-week benefit, walk gains by 36 weeks open-label](https://pepvault.app/research/ss-31-reid-thompson-2021)
- [All 12 studies](https://pepvault.app/research#ss-31)

### Compared with

- [MOTS-c vs SS-31](https://pepvault.app/peptides/compare/mots-c-vs-ss-31)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Unit (on a syringe)](https://pepvault.app/glossary/syringe-units)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on SS-31](https://pepvault.app/research#ss-31)

## The library

- [SS-31](https://pepvault.app/peptides/ss-31)
- [SS-31 dose guide](https://pepvault.app/lab/dosage/ss-31)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
